Galena Biopharma Launches Anti-Nausea Drug Zuplenz
July 29, 2015 at 15:31 PM EDT
Galena Biopharma shares are up 5% after announcing the launch of an anti-nausea drug known as Zuplenz, indicated for use in post-chemo, post-radiation and post-surgical patients.